Boston Scientific Japan, on 20 February 2013, reached an agreement with Fukuda Denshi to market and sell the Boston Scientific Spinal Cord Precision Plus System and accessories throughout. Fukuda Denshi will begin distributing Boston Scientific Neuromodulation products on 1 April 2013.
Boston Scientific is developer of Neuromodulation devices used to manage chronic neuropathic pain. The Boston Scientific Spinal Cord Precision Plus System is the only device on the market, according to a company release, with 16 dedicated, independent current sources designed to precisely target patient pain and the only device to offer patients wireless charging and wireless remote control to treat their pain. The remote controller is designed for patient ease of use due to its small size.
“We are pleased to reach this agreement with Fukuda Denshi to distribute our Neuromodulation products in Japan,” said Yusuke Naiki, president, Boston Scientific Japan. “Fukuda Denshi has been an established player in Japan for more than 70 years, with a proven track record and a long and successful history of delivering results. We look forward to a successful relationship.”
According to the company, currently, more than 60,000 patients worldwide are using the Precision Plus System.